A brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a study published online Dec. 9 in Pediatric Blood & Cancer.

The human EphA3 gene was discovered in a pre-B acute lymphoblastic leukemia (pre-B-ALL ... In this study, we show that IIIA4 antibody treatment of EphA3-positive human pre-B-ALL xenografts ...

Leukaemia that does not go away with treatment is called refractory leukaemia. Leukaemia that comes back after treatment is called relapsed disease. It can be more difficult to treat relapsed or ...

National Cancer Institute: “Chronic Lymphocytic Leukemia Treatment (PDQ) -- Health Professional Version,” “Adult Acute Myeloid Leukemia Treatment (PDQ) -- Patient Version.” MD Anderson ...